Search - tctmd.com

Displaying 21 - 40 of 54

Sort: Relevancy | Date

Presentation ESC 2021

One-month Dual Antiplatelet Therapy Followed by Clopidogrel Monotherapy in Acute Coronary Syndrome:

Presenter: Hirotoshi Watanabe

August 31, 2021

News Conference News

In ACS, Clopidogrel Monotherapy After 1-Month DAPT Falls Short: STOPDAPT-2 ACS

Shelley Wood

August 30, 2021

News Conference News ESC 2021

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

Shelley Wood

August 28, 2021

News Daily News

Colchicine Lowers CVD Risk No Matter When Past ACS Occurred: LoDoCo2

Michael O'Riordan

August 26, 2021

News Conference News ESC 2021

Prasugrel Tops Ticagrelor in ACS Across the eGFR Spectrum: ISAR-REACT 5

Todd Neale

August 24, 2021

News Daily News

COVID-19 Infection Boosts Acute MI, Stroke Risk in Early Weeks

L.A. McKeown

August 03, 2021

News Conference News HRS 2021

Heart Failure Patients With AF Benefit From Early Rhythm Control

Shelley Wood

July 30, 2021

News Daily News

Acute MI More Common After TAVI vs SAVR, Real-World Data Suggest

Caitlin E. Cox

July 19, 2021

News Daily News

De-escalation Tops Other DAPT Tactics for ACS: Meta-analysis

Yael L. Maxwell

July 16, 2021

News Daily News

Most Cardiac Complications From MIS-C Resolve Within Months

Shelley Wood

July 15, 2021

News Daily News

DOACs May Have Advantage Over VKAs After TAVI, Study Hints

Todd Neale

July 14, 2021

News Daily News

Rare Clotting Complication Seen After mRNA Vaccine: Case Report

Caitlin E. Cox

June 28, 2021

News Daily News

Delays at Every Stage of STEMI Add Up to Worse Care for Women

L.A. McKeown

June 25, 2021

News Daily News

Complete Revascularization Best for Most ACS Patients With MVD

Michael O'Riordan

June 25, 2021

News Daily News

Korean Kawasaki Cases Dropped Sharply Amid COVID-19 Controls

Shelley Wood

June 07, 2021

News Conference News ACC 2021

FFR Doesn’t Beat Angio for Complete Revasc in STEMI: FLOWER-MI

Caitlin E. Cox

May 25, 2021

News Conference News EuroPCR 2021

Ultrathin Orsiro Performs Well in All-Comers, Interim CASTLE Data Indicate

Caitlin E. Cox

May 24, 2021

News Conference News ACC 2021

Evinacumab Lowers Triglycerides in Severe Hypertriglyceridemia

Yael L. Maxwell

May 16, 2021

Presentation Fellows 2021

Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS): What You Need to Know

Presenter: Celina M. Yong

May 09, 2021

Advertisement

One-month Dual Antiplatelet Therapy Followed by Clopidogrel Monotherapy in Acute Coronary Syndrome:

In ACS, Clopidogrel Monotherapy After 1-Month DAPT Falls Short: STOPDAPT-2 ACS

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

Colchicine Lowers CVD Risk No Matter When Past ACS Occurred: LoDoCo2

Prasugrel Tops Ticagrelor in ACS Across the eGFR Spectrum: ISAR-REACT 5

COVID-19 Infection Boosts Acute MI, Stroke Risk in Early Weeks

Heart Failure Patients With AF Benefit From Early Rhythm Control

Acute MI More Common After TAVI vs SAVR, Real-World Data Suggest

De-escalation Tops Other DAPT Tactics for ACS: Meta-analysis

Most Cardiac Complications From MIS-C Resolve Within Months

DOACs May Have Advantage Over VKAs After TAVI, Study Hints

Rare Clotting Complication Seen After mRNA Vaccine: Case Report

Delays at Every Stage of STEMI Add Up to Worse Care for Women

Complete Revascularization Best for Most ACS Patients With MVD

Korean Kawasaki Cases Dropped Sharply Amid COVID-19 Controls

FFR Doesn’t Beat Angio for Complete Revasc in STEMI: FLOWER-MI

Ultrathin Orsiro Performs Well in All-Comers, Interim CASTLE Data Indicate

Evinacumab Lowers Triglycerides in Severe Hypertriglyceridemia

Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS): What You Need to Know

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content